DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS
DIRECTOR'S OFFICE
BOARD OF OPTOMETRY - GENERAL RULES
Filed with the secretary of state on
These rules take
effect immediately upon filing with the secretary of state unless adopted under
section 33, 44, or 45a(6)(9) of the administrative procedures act
of 1969, 1969 PA 306, MCL 24.233, 24.244, or 24.245a. Rules adopted under
these sections become effective 7 days after filing with the secretary of
state.
(By authority conferred on the director of the department of licensing and regulatory affairs by sections 16145, 16148, 16174, 16287, and 17431 of the public health code, 1978 PA 368, MCL 333.16145, 333.16148, 333.16174, 333.16287, and 333.17431 and Executive Reorganization Order Nos. 1991-9, 1996-2, 2003-1, and 2011-4, MCL 338.3501, 445.2001, 445.2011, and 445.2030)
R 338.305, R 338.309, R 338.311, R 338.313, R 338.315, R 338.317, R 338.319, R 338.320, and R 338.321 of the Michigan Administrative Code are amended and R 338.304 is rescinded, as follows:
PART 1. GENERAL PROVISIONS
R 338.304 Minimum English
language standard. Rescinded.
Rule 4. (1) Pursuant to section 16174(1)(d) of the
code, MCL 333.16174(1)(d) an applicant who applies for initial licensure shall
demonstrate a working knowledge of the English language if his or her educational
or training program was taught outside the United States, unless exempted under
subrule (3) of this rule.
(2) To demonstrate a working knowledge of the English
language, an applicant shall submit proof that he or she obtained a total score
of not less than 84 on the test of English as a foreign language internet-based
test (TOEFL-IBT) administered by the Educational Testing Service and obtained
the following scores:
(a) A score of 21
for the speaking section of the test.
(b) A score of 21
for the writing section of the test.
(c) A score of 21
for the listening section of the test.
(d) A score of 21 for
the reading section of the test.
(3) If an applicant’s
educational or training program was taught in English within one or more of the
following countries, he or she is exempted from the requirements of subrule (1)
of this rule:
(a) Canada, except Quebec.
(b) England.
(c) Ireland.
(d) New Zealand.
(e) Australia.
R 338.305 Professional optometric degree program; approval standards.
Rule 5. (1) The board approves and adopts by reference
the standards of the Accreditation Council on Optometric Education (ACOE) set
forth in the publication entitled "Accreditation Manual: Professional
Optometric Degree Programs," dated August 2014, and revised July
1, 2017 revised January 2019, and updated August 2019, which provide
for the accreditation of professional optometric degree programs.
(2) A professional optometric degree program accredited by
the Accreditation Council on Optometric Education ACOE is considered
approved by the board.
(3) Copies of the Accreditation Manual of the Accreditation
Council on Optometric Education ACOE are available free of charge
from the American Optometric Association’s Association, 243 N. Lindbergh
Blvd., St. Louis, MO 63141 or from the association's website at http://www.aoa.org https://www.aoa.org/optometrists/for-educators/accreditation-council-on-optometric-education/accreditation-resources-and-guidance/optometric-degree-programs.
Printed copies also are available for inspection and distribution at a cost
of 10 cents per page from the Bureau of Professional Licensing, Department
of Licensing and Regulatory Affairs, Ottawa Building, 611 W. Ottawa, P.O. Box
30670, Lansing, MI Michigan 48909.
PART 2. LICENSES
R 338.309 Licensure by endorsement.
Rule 9. (1) An applicant for a Michigan optometry
license licensure by endorsement shall hold an active license in
good standing in another state or province of Canada and submit a completed
application on forms a form provided by the department, together with
the requisite fee. In addition to meeting the requirements of the code and the
administrative rules promulgated under the code, an applicant shall comply with
all of the following requirements as noted by (√): have
graduated from a professional optometric degree program approved by the board,
pursuant to R 338.305, and satisfy the requirements of this rule.
(2) An applicant shall be an optometrist who is engaged
in the practice of optometry, holds a doctor of optometry degree, and is
currently licensed at the highest level authorized in another state of the
United States or province of Canada that has licensure requirements that are
equivalent to those required in this state, as determined by the board. This
subrule does not grant license authority that exceeds the level of privileges
granted to individuals who are licensed under the code to engage in the
practice of optometry.
(3) An applicant shall have achieved a passing score on
parts I, II, and III of the NBEO examinations, including a passing score on the
TMOD examination, in a state of the United States or province of Canada for his
or her initial licensure.
(4) An applicant who was first licensed in another
state of the United States or province of Canada is presumed to have met the requirements
of section 16186(1)(a) and (b) of the code, MCL 333.16186(1)(a) and (b), if he
or she meets all of the following requirements:
(a) Provides verification of his or her license by
the licensing agency of another state of the United States or province of
Canada in which the applicant holds a current license or ever held a license as
an optometrist, which includes, but is not limited to, showing proof of any
disciplinary action taken or pending disciplinary action imposed upon the
applicant.
(b) Achieves a minimum scaled score of 75 on the
examination of Michigan laws and rules related to the practice of optometry
that is developed and administered by the department, or an entity approved by
the department.
(5) An applicant shall hold a license granting
therapeutic prescriptive certification at the highest level authorized in the
state of the United States or province of Canada where he or she currently
practices.
|
(a) An applicant who is licensed in another state. |
Licensed for less than 3 years. |
Licensed 3 years or more. |
|
|
(i) |
Establish that he or she is of good moral character as defined under 1974 PA 381, MCL 338.41 to 338.47. |
√
|
√
|
|
(ii) |
Submit fingerprints as required under section 16174(3) of the code, MCL 333.16174. |
√
|
√
|
|
(iii) |
Graduate from a school of optometry approved by the board pursuant to R 338.305. |
√
|
|
|
(iv) |
Achieve a passing score on parts I, II, and III of the NBEO examination, including a passing score on the TMOD examination given by NBEO or its successor organization. |
√
|
|
|
(v) |
Achieve a minimum scaled score of 75 on the examination of Michigan laws and rules related to the practice of optometry that is developed and administered by the department, or an entity approved by the department. |
√
|
√
|
|
(vi) |
Hold a license in good standing granting therapeutic prescriptive certification at the highest level authorized in the state of the United States where the applicant is currently licensed. |
√
|
√
|
|
(vii) |
Hold a valid cardiopulmonary resuscitation (CPR) certificate issued by any of the following: (i) The Red Cross. (ii) The American Heart Association. (iii) An accredited hospital. (iv) An organization or institution comparable to those identified in subparagraphs (i) to (iv) of this paragraph. |
√
|
√
|
|
(viii) |
Comply with both of the following:
(A) Disclose each license, registration, or certification in a health profession or specialty issued by any other state, the United States military, the federal government, or another country on the application form.
(B) Satisfy the requirements of section 16174(2) of the code, MCL 333.16174, which includes verification from the issuing entity showing that disciplinary proceedings are not pending against the applicant and sanctions are not in force at the time of application. |
√
|
√
|
|
(b) An applicant who is licensed in a province of Canada. |
Licensed less than 10 years. |
Licensed 10 years or more. |
|
|
(i) |
Establish that he or she is of good moral character as defined under 1974 PA 381, MCL 338.41 to 338.47. |
√
|
√
|
|
(ii) |
Submit fingerprints as required under section 16174(3) of the code, MCL 333.16174. |
√ |
√
|
|
(iii) |
Graduate from a school of optometry approved by the board pursuant to R 338.305. |
√
|
√
|
|
(iv) |
Achieve a passing score on parts I, II, and III of the NBEO examination, including a passing score on the TMOD examination given by NBEO or its successor organization. |
√ |
|
|
(v) |
Achieve a minimum scaled score of 75 on the examination of Michigan laws and rules related to the practice of optometry that is developed and administered by the department, or an entity approved by the department. |
√
|
√
|
|
(vi) |
Hold a license in good standing granting therapeutic prescriptive certification at the highest level authorized in the province of Canada where the applicant is currently licensed. |
√
|
√
|
|
(vii) |
Hold a valid CPR certificate issued by any of the following: (i) The Red Cross. (ii) The American Heart Association. (iii) An accredited hospital. (iv) An organization or institution comparable to those identified in subparagraphs (i) to (iv) of this paragraph. |
√
|
√
|
|
(viii) |
Comply with both of the following:
(A) Disclose each license, registration, or certification in a health profession or specialty issued by any other state, the United States military, the federal government, or another country on the application form.
(B) Satisfy the requirements of section 16174(2) of the code, MCL 333.16174, which includes verification from the issuing entity showing that disciplinary proceedings are not pending against the applicant and sanctions are not in force at the time of application. |
√
|
√
|
R 338.311 Limited licenses.
Rule 11. (1) The board may issue an educational limited
license, pursuant to section 16182(2)(a) of the code, MCL 333.16182(2)(a),
to an individual who meets the requirements of the code and the
administrative rules promulgated under the code and who has graduated from
a board-approved professional optometric degree program, or who will graduate
from the program not more than 3 months after applying for an educational limited
license, and who is enrolled in a postgraduate course of study or participates in
a residency program that is offered by the United States department Department
of veterans Veterans affairs Affairs or a
board-approved institution.
(2) The board may issue a clinical academic limited license,
pursuant to section 16182(2)(c) of the code, MCL 333.16182(2)(c), to an
individual who meets the requirements of the code and the administrative
rules promulgated under the code and who is a graduate of a board-approved
professional optometric degree program and who is employed as a faculty member
at a board-approved professional optometric degree program. An optometrist who
is licensed under this subrule may perform procedures upon patients while employed
as a faculty member at a board-approved professional optometric degree program,
if these procedures are performed under the general supervision of a faculty member
who is fully licensed as an optometrist. An individual who is licensed under
this subrule shall not do either of the following:
(a) Hold himself or herself out to the public as being engaged in the practice of optometry other than as a faculty member.
(b) Provide optometric services outside of his or her employment as a faculty member.
(3) An individual who applies for a limited license under
section 16182(2)(a) or (c) of the code, MCL 333.16182(2)(a) or (c),
shall meet all of the following requirements:
(a) Comply with section 16174 of the code, MCL 333.16174.
(b) Submit proof of graduation from an accredited professional optometric degree program that is approved by the board or from a non-accredited professional optometric degree program that is approved by the board, pursuant to R 338.305.
(c) Submit proof of appointment to either of the following:
(i) A postgraduate course of study or a residency program, pursuant to subrule (1) of this rule.
(ii) A faculty position at a board-approved professional optometric degree program, pursuant to subrule (2) of this rule.
(4) Limited licenses, pursuant to subrules (1) and (2) of this rule, may be renewed annually at the discretion of the board.
(5) Applicants for renewal of a clinical academic limited license shall submit evidence of having completed 10 hours of board-approved continuing education in pharmacological management of ocular conditions required for the year.
Rule 13. (1) An applicant whose Michigan license
has lapsed may be relicensed, under the provisions of
section 16201(3) or (4) of the code, MCL 333.16201(3) or (4), as applicable,
if the applicant meets the requirements of the code and the administrative
rules promulgated under the code and satisfies may be relicensed by complying
with the following requirements as noted by (√):
|
(a) An applicant who has let his or her Michigan license lapse and is not currently licensed in another state or in Canada. |
Lapsed 3 years or less. |
Lapsed more than 3 years, but less than 6 years. |
Lapsed 6 years or more. |
|
|
|
|
√
|
√
|
√
|
|
|
|
√
|
√
|
√ |
|
|
|
|
√
|
√ |
|
|
|
√
|
√
|
√ |
|
|
|
|
√
|
√ |
|
|
|
|
|
√ |
|
|
(A) Disclose each license, registration, or certification on the application form.
(B) Satisfy the requirements of section 16174(2) of the code, MCL 333.16174, which includes verification from the issuing entity showing that disciplinary proceedings are not pending against the applicant and sanctions are not in force at the time of application. |
√
|
√
|
√
|
|
(b) An applicant who has let his or her Michigan license lapse and is currently licensed in another state or in Canada. |
Lapsed 3 years or less. |
Lapsed more than 3 years, but less than 6 years. |
Lapsed 6 years or more. |
|
|
(i) |
Submit a completed application on a form provided by the department, together with the required fee. |
√
|
√
|
√
|
|
(ii) |
Establish that he or she is of good moral character as defined under 1974 PA 381, MCL 338.41 to 338.47. |
√
|
√
|
√ |
|
(iii) |
Submit fingerprints as required under section 16174(3) of the code, MCL 333.16174. |
|
√
|
√ |
|
(iv) |
Submit proof of having completed 40 hours of continuing education as required under R 338.321, which was earned within the 2-year period immediately preceding the date of relicensure, subject to both of the following:
(A) At least 2 of the 40 hours of continuing education must be in pain and symptom management, as provided under R 338.321(3).
(B) If certified to administer therapeutic pharmaceutical agents, at least 20 of the 40 hours of continuing education must be in pharmacological management of ocular conditions, as provided in R 338.321(2), and the applicant shall hold a current CPR certificate. |
√
|
√
|
√ |
|
(v) |
Achieve a minimum scaled score of 75 on the examination of Michigan laws and rules related to the practice of optometry that is developed and administered by the department, or an entity approved by the department. |
|
√
|
√ |
|
(vi) |
An applicant who is or has ever been licensed, registered, or certified in a health profession or specialty by any other state, the United States military, the federal government, or another country, shall do both of the following:
(A) Disclose each license, registration, or certification on the application form.
(B) Satisfy the requirements of section 16174(2) of the code, MCL 333.16174, which includes verification from the issuing entity showing that disciplinary proceedings are not pending against the applicant and sanctions are not in force at the time of application. |
√
|
√
|
√
|
(2) If relicensure is granted and it is determined that a sanction has been imposed by another state, the United States military, the federal government, or another country, the disciplinary subcommittee may impose appropriate sanctions under section 16174(5) of the code, MCL 333.16174.
R 338.315 Certification to administer topical ocular diagnostic pharmaceutical agents;
application; qualifications; adoption of standards; prohibitions.
Rule 15. (1) An applicant for certification to administer
a topical ocular diagnostic pharmaceutical agent in the practice of optometry
shall submit a completed application, on a form provided by the department,
together with the requisite fee. In addition to meeting the other requirements
of the code and the administrative rules promulgated pursuant to under
the code, an applicant shall satisfy all of the following requirements:
(a) Successfully complete a course of study in general
and clinical pharmacology related to the practice of optometry as required in
section 17412(2)(a) of the code, MCL 333.17412. The course of study must
include passing an examination on general and ocular pharmacology. The
applicant shall be has considered to have successfully
completed the required course of study upon being when
he or she has been granted the credit hours designated for the course of
study by the teaching institution where the course is offered.
(b) Establish a board-approved emergency treatment plan,
pursuant to section 17412(2)(d) of the code, MCL 333.17412(2)(d), for
the management and referral of patients who experience any adverse drug
reaction. To be board-approved, the emergency treatment plan must include
all of the following:
(i) Patient instructions related to an adverse drug reaction.
(ii) A referral procedure for a patient reporting an adverse drug reaction.
(iii) The names and contact information of not less than 3 physicians, clinics, or hospitals to whom the patient reporting an adverse drug reaction may be referred.
(iv) A documentation procedure for the information to be included in the patient’s medical record regarding the report of an adverse drug reaction.
(c) Successfully complete a course in CPR as required by section 17412(2)(c) of the code, MCL 333.17412, approved by the department of health and human services, and offered or approved by any of the following:
(i) The Red Cross.
(ii) The American Heart Association.
(iii) An accredited hospital.
(iv) An organization or institution comparable to those identified in paragraphs (i) to (iii) of this subdivision.
basic life support that is offered by an organization or
institution approved by the board, pursuant to section 17412(2)(c) of the code,
MCL 333.17412(2)(c). The board approves and adopts by reference the standards
for credentialing in basic and advanced life support by the American Heart Association
in the Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care
for Professional Providers set forth in the "2015 American Heart Association
(AHA) Guidelines for CPR and ECC" that was published in the AHA journal
"Circulation", volume 132, issue 18 supplement 2, November 3, 2015.
A copy of the guidelines may be obtained at no cost from the American Heart
Association's website at https://circ.ahajournals.org/content/132/18_suppl_2.toc
. A copy of the guidelines is available for inspection and distribution to the
public at cost from the Department of Licensing and Regulatory Affairs, Ottawa
Building, 611 W. Ottawa, P.O. Box 30670, Lansing, MI 48909.
(2) A licensed optometrist shall not use diagnostic pharmaceutical agents in the practice of optometry unless the optometrist has been certified by the board as being qualified to administer topical ocular diagnostic pharmaceutical agents.
R 338.317 Certification to administer and prescribe therapeutic pharmaceutical agents;
application; qualifications.
Rule 17. (1) An applicant for certification to administer
and prescribe a therapeutic pharmaceutical agent in the practice of optometry
shall submit a completed application, on a form provided by the department,
together with the requisite fee. In addition to meeting the other requirements
of the code and the administrative rules promulgated pursuant to under
the code, an applicant shall satisfy all of the following requirements:
(a) Meet the certification requirements to administer diagnostic pharmaceutical agents under R 338.315.
(b) Successfully complete a course of study relating to the didactic and clinical use of therapeutic pharmaceutical agents as required in section 17435(2)(b) of the code, MCL 333.17435.
(c) Establish a board-approved management plan that is
in compliance complies with section 17435(2)(c) of the code, MCL
333.17435(2)(c).
(2) A licensed optometrist shall not administer or prescribe therapeutic pharmaceutical agents in the practice of optometry unless the optometrist has been certified by the board as being qualified to administer and prescribe therapeutic pharmaceutical agents.
PART 3. CONTINUING EDUCATION
R 338.319 Adoption of standards and criteria by reference; board approval by
application.
Rule 19. (1) The board approves and adopts by reference
the standards and criteria of the Council on Optometric Practitioner Education (COPE)
for accreditation of an activity or qualification of a course that are
set forth in the publications entitled “Activity Accreditation Manual,” revised
February 2017, and “Course Qualification Manual,” revised February 2017. publication
entitled "Criteria for COPE Qualification of Continuing Education," revised
July 2015. A copy of the publication publications may be
obtained at no cost from the Association of Regulatory Boards of Optometry’s
Optometry, 200 South College St., Suite 2030 Charlotte, NC 28202, or
from the council's website at http://www.arbo.org. Printed copies also
are available for inspection and distribution at a
cost of 10 cents per page from the Bureau of Professional Licensing,
Department of Licensing and Regulatory Affairs, Ottawa Building, 611 W. Ottawa,
P.O. Box 30670, Lansing, MI Michigan 48909.
(2) A continuing education program related to the practice of optometry that has been accredited by COPE is considered approved by the board.
(3) A continuing education program that is not accredited by COPE or approved as provided in R 338.320 may apply for board approval by submitting an application to the department. The application must be received not less than 90 calendar days before the program presentation. The application must be reviewed by the board’s continuing education subcommittee. After review and recommendation of the program by the board’s continuing education subcommittee, approval of the continuing education program may be granted after a vote of the full board.
(4) Applications for approval of a continuing education program must include all the following:
(a) The sponsor’s name.
(b) The sponsor’s address.
(c) The program name.
(d) The program date.
(e) The program location.
(f) The program outline, including all of the following:
(i) An explanation of how the program is designed to further educate the licensee through acquisition and application of knowledge, which results in improved patient outcomes.
(ii) The topics and the name of the speaker of each topic.
(iii) The times of the specific topics and breaks included in the program.
(g) The résumé of each speaker or instructor for the program.
(h) A description of the delivery method, or methods to be used, and the techniques that will be employed to assure active participation.
(i) A brief description of the sponsoring organization.
(j) The name, title, and address of the program director and a description of his or her qualifications to direct the program.
(k) A description of how participants will be notified that continuing education credit has been earned.
(l) A description of the physical facilities or laboratory available to assure a proper learning environment.
(m) A description of how attendance is monitored and the name of the person monitoring attendance.
(n) The number of hours of course instruction including all of the following:
(i) The number of hours related to clinical optometry, which may include any of the following COPE categories:
(A) Contact lenses (CL).
(B) Functional vision/pediatrics (FV).
(C) General optometry (GO).
(D) Low vision/vision impairment & rehabilitation (LV).
(E) Public health (PB).
(ii) The number of hours related to practice management, which may include the following COPE categories:
(A) Practice management (PM).
(B) Ethics/jurisprudence (EJ).
(iii) The number of hours related to pharmaceutical management, which may include any of the following COPE categories:
(A) Glaucoma (GL).
(B) Injection skills (IS).
(C) Laser procedures (LP).
(D) Peri-operative management of ophthalmic surgery (PO).
(E) Refractive surgery management (RS).
(F) Surgery procedures (SP).
(G) Treatment and management of ocular disease: anterior segment (AS).
(H) Treatment and management of ocular disease: posterior segment (PS).
(I) Neuro-optometry (NO).
(J) Oral pharmaceuticals (OP).
(K) Pharmacology (PH).
(L) Principles of diagnosis (PD).
(M) Systemic/ocular disease (SD).
(iv) The number of hours related to pain management, which may include any of the following COPE categories:
(A) Oral pharmaceuticals (OP).
(B) Pharmacology (PH).
(C) Treatment and management of ocular disease: anterior segment (AS).
(D) Treatment and management of ocular disease: posterior segment (PS).
(E) Functional vision/pediatrics (FV).
R 338.320 Approved continuing education; limitations; documentation.
Rule 20. The board approves all of the following as continuing education if the subject matter falls within an approved COPE category as listed in R 338.319(4)(n):
|
|
Activity and Proof of Completion |
Number of Continuing Education Hours Granted or Permitted for Activity |
|
(1) |
Successful completion of a course or courses offered for credit by an accredited optometry school or college approved by the board under R 338.305.
If audited, a licensee shall submit an official transcript documenting successful completion of the course. |
Ten hours of continuing education
Fifteen hours of continuing education |
|
(2) |
Successful completion of a continuing education program offered by an accredited optometry school or college approved by the board under R 338.319.
If audited, a licensee shall submit a copy of a letter or certificate of completion showing the licensee’s name, number of credits earned, sponsor name or the name of the organization that approved the program or activity for continuing education credit, and the date or dates on which the program was held or activity completed. |
One continuing education hour |
|
(3) |
Attendance at a continuing education program related to the practice of optometry offered by an educational program approved by the board under R 338.319(3) or approved by another state board of optometry.
If audited, a licensee shall submit a copy of a letter or certificate of completion showing the licensee’s name, number of credits earned, sponsor name or the name of the organization that approved the program or activity for continuing education credit, and the date or dates on which the program was held or activity completed. |
One continuing education hour |
|
(4) |
Initial presentation of or at a continuing education program approved by the board.
If audited, a licensee shall submit a letter from the program’s sponsor, verifying the licensee’s presentation of educational materials and lecture at the continuing education program. |
One continuing education in the appropriate COPE category
|
|
(5) |
Attendance at a continuing education program related to optometric topics approved for category 1 continuing education by the Michigan board of medicine or the Michigan board of osteopathic medicine and surgery.
If audited, a licensee shall submit a copy of a letter or certificate of completion showing the licensee’s name, number of credits earned, sponsor name or the name of the organization that approved the program or activity for continuing education credit, and the date or dates on which the program was held or activity completed. |
One continuing education hour in clinical optometry |
|
(6) |
Attendance at a continuing education program related to optometric pharmacological topics approved for continuing education by the Michigan board of pharmacy.
If audited, a licensee shall submit a copy of a letter or certificate of completion showing the licensee’s name, number of credits earned, sponsor name or the name of the organization that approved the program or activity for continuing education credit, and the date or dates on which the program was held or activity completed. |
One continuing education hour in pharmacological
management |
|
(7) |
Initial presentation of a scientific exhibit, poster, or paper to a professional optometric organization.
If audited, the licensee shall submit a copy of the document presented with evidence of presentation or a letter from the program sponsor verifying the date of the presentation. |
Two hours of continuing education in clinical optometry |
|
(8) |
Initial publication of either of the following:
(a) A scientific article relating to the practice of optometry in a peer-reviewed journal or periodical.
(b) A chapter or a portion of a chapter related to the practice of optometry in either a professional health care textbook or peer-reviewed textbook.
If audited, the licensee shall submit a copy of the publication that identifies the licensee as the author or a publication acceptance letter and documentation of the peer-review process. |
Six hours of continuing education in clinical optometry |
|
(9) |
Participating on either of the following:
(a) A peer review committee dealing with quality of patient care as it relates to the practice of optometry.
(b) A national or state committee, board, council, or association related to the practice of optometry.
Participation on a committee, board, council, or association is considered acceptable by the board if it enhances the participant’s knowledge and understanding of the field of optometry.
If audited, the licensee shall submit a letter from an organization official verifying the licensee’s participation in at least 50% of the regularly scheduled meetings of the committee, board, council, or association. |
Six hours of continuing education in clinical optometry |
|
(10) |
Taking and passing any nationally recognized advanced competency examination in optometry. |
Every 2 years, 12 hours of continuing education in pharmacology
management or clinical optometry are earned |
R 338.321 License renewal; continuing education, requirements, limitations.
Rule 21. (1) An applicant for license renewal shall satisfy
the requirements of the Public Health Code General Rules, R 338.7001 to R 338.7005,
and shall accumulate not less than 40 continuing education hours approved by
the board pursuant to R 338.319 or R 338.320 during the 2 years immediately preceding
the expiration date of the license the date of application for
renewal.
(2) An applicant for license renewal who holds certification to administer topical ocular diagnostic pharmaceutical agents or certification to administer and prescribe therapeutic pharmaceutical agents, or both, shall do both of the following:
(a) accumulate Accumulate not less
than 20 hours of board-approved continuing education in pharmacological management
of ocular conditions. The 20 required hours are part of, and not in addition
to, the 40 hours required in subrule (1) of this rule. A continuing education program
that falls within the COPE categories listed in R 338.319(4)(n)(iii)(A) to (M) meets
the requirements of this subrule subdivision.
(b) Hold a valid CPR certificate issued by any of the following:
(i) The Red Cross.
(ii) The American Heart Association.
(iii) An accredited hospital.
(iv) An organization or institution comparable to those identified in paragraphs (i) to (iii) of this paragraph.
(3) An applicant for license renewal shall accumulate not less than 2 hours of board approved continuing education in pain and symptom management related to the practice of optometry. A continuing education program that falls within the COPE categories listed in R 338.319(4)(n)(iv)(A) to (E) meets the requirements of this subrule. Continuing education hours in pain and symptom management, as they relate to the practice of optometry, may include, but are not limited to, the following:
(a) Ethics and health policy related to pain.
(b) Pain definitions.
(c) Basic sciences related to pain, including pharmacology, psychology, sociology, and anthropology.
(d) Clinical sciences related to pain, including specific pain conditions and pain in special contexts and settings.
(e) Clinician-patient communications related to pain.
(f) Management of pain, including evaluation and treatment; non-pharmacological and pharmacological management.
(g) Ensuring quality pain care.
(h) Michigan programs and resources relevant to pain.
(4) A minimum of 20 of the required continuing education
hours must be completed in a face-to-face real-time live, synchronous
learning format. The remaining hours may be completed in any other format including
but not limited to self-evaluation journal tests, multimedia education, real
time webinars, video conferencing, webcasts, and podcasts.
(5) An applicant for license renewal may earn a maximum of 9 continuing education hours per licensure cycle in practice management. A continuing education program that falls within the COPE categories listed in R 338.319(4)(n)(ii)(A) and (B) meets the requirements of this subrule.
(6) Submission of an application for renewal constitutes the
applicant's certificate of compliance with the requirements of this rule. An
optometrist shall retain documentation of meeting the requirements of this rule
for a period of 4 years from the date of applying for license renewal. The
board may require an applicant or licensee to submit evidence to demonstrate
compliance with this rule. Failure to comply with this rule is a violation of
section 16221(h) of the code, MCL 333.16221(h).
(7) A request for a waiver under section 16205 of the code, MCL 333.16205, must be received by the department before the expiration date of the license.